Intellectia LogoIntellectia
Product
Resources
Markets
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns
Daytrading Center

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks
Pricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. MMSI
stocks logo

MMSI

-
Add to WatchlistAdvanced Chart
$
0.000
0(0.000%)1D
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q2
FY2025Q3
FY2025Q4
372.47M
+10.2%
0.848
-7.8%
370.78M
+9.1%
0.789
-8.23%
386.82M
+8.91%
0.842
-9.48%
Estimates Revision
The market is revising Upward the revenue expectations for Merit Medical Systems, Inc. (MMSI) for FY2025, with the revenue forecasts being adjusted by 0.45% over the past three months. During the same period, the stock price has changed by -6.16%.
Revenue Estimates for FY2025
Revise Upward
up Image
+0.45%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
down Image
-8.4%
In Past 3 Month
Stock Price
Go Down
down Image
-6.16%
In Past 3 Month
9 Analyst Rating
up Image0
Wall Street analysts forecast MMSI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MMSI is 107.11 USD with a low forecast of 100.00 USD and a high forecast of 112.00  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
8 Buy
1 Hold
0 Sell
Strong Buy
up Image0
Current: 84.080
sliders
Low
100.00
Averages
107.11
High
112.00
up Image0
Current: 84.080
sliders
Low
100.00
Averages
107.11
High
112.00
Piper Sandler
Jason Bednar
Overweight
maintain
$106 -> $110
2025-05-23
Reason
Piper Sandler
Jason Bednar
Price Target
$106 -> $110
2025-05-23
maintain
Overweight
Reason
Piper Sandler analyst Jason Bednar raised the firm's price target on Merit Medical to $110 from $106 and keeps an Overweight rating on the shares. The firm is updating its Merit Medical model for several recent items, including the Biolife transaction announced earlier this week and the segment revenue recasting that was done effective Q1.
Wells Fargo
Overweight
maintain
$106 -> $108
2025-05-21
Reason
Wells Fargo
Price Target
$106 -> $108
2025-05-21
maintain
Overweight
Reason
Wells Fargo raised the firm's price target on Merit Medical to $108 from $106 and keeps an Overweight rating on the shares. The firm notes the company has announced it acquired hemostasis products, StatSeal and WoundSeal, from BioLife for $120M in cash or about 6.7-times forward year sales. The deal is expected to add $10M-$11M in revenue and be a penny dilutive to EPS in FY25.
Canaccord
John Young
Buy
maintain
$108 -> $112
2025-05-21
Reason
Canaccord
John Young
Price Target
$108 -> $112
2025-05-21
maintain
Buy
Reason
Canaccord analyst John Young raised the firm's price target on Merit Medical to $112 from $108 and keeps a Buy rating on the shares. The firm noted their announced acquisition of BioLife and the company's reaffirmation of its FY25 guidance, and updated it to reflect the anticipated impact from the merger.
Canaccord
John Young
Buy
downgrade
$127 -> $108
2025-04-25
Reason
Canaccord
John Young
Price Target
$127 -> $108
2025-04-25
downgrade
Buy
Reason
Canaccord analyst John Young lowered the firm's price target on Merit Medical to $108 from $127 and keeps a Buy rating on the shares. The firm said after a strong Q1 print, Merit's margin expansion story just got more complicated due to tariffs. Much of the investor thesis on Merit Medical has been on margin expansion and tariffs are creating a formidable hurdle to that continued pace of expansion.
Piper Sandler
Overweight
downgrade
$112 -> $106
2025-04-25
Reason
Piper Sandler
Price Target
$112 -> $106
2025-04-25
downgrade
Overweight
Reason
Piper Sandler lowered the firm's price target on Merit Medical to $106 from $112 and keeps an Overweight rating on the shares. The firm notes the company announced Q1 results that once again beat at both the top and bottom lines, with the gross margin expansion in the period notable. Unsurprisingly, estimated tariff headwinds and a below-expected start to China dominated much of the Q&A, but Piper likes that there's a line drawn in the sand on tariffs and that management has maintained its usual conservative approach in setting forward expectations.
Wells Fargo
Larry Biegelsen
Overweight
downgrade
$117 -> $106
2025-04-25
Reason
Wells Fargo
Larry Biegelsen
Price Target
$117 -> $106
2025-04-25
downgrade
Overweight
Reason
Wells Fargo analyst Larry Biegelsen lowered the firm's price target on Merit Medical to $106 from $117 and keeps an Overweight rating on the shares. The firm notes Merit Medical reported Q1 sales/EPS ahead of consensus and reaffirmed FY25 sales guidance. FY25 EPS outlook is impacted by tariffs and the convert. Merit Medical expects to see a lesser, annualized impact in FY26 due to mitigation strategies, Wells adds.
See All Ratings

Valuation Metrics

The current forward P/E ratio for Merit Medical Systems Inc (MMSI.O) is 25.20, compared to its 5-year average forward P/E of 26.54. For a more detailed relative valuation and DCF analysis to assess Merit Medical Systems Inc 's fair value, click here.
    Forward PE
    Forward EV/EBITDA
    Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PE
26.54
Current PE
25.20
Overvalued PE
30.09
Undervalued PE
22.99

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average EV/EBITDA
18.03
Current EV/EBITDA
18.64
Overvalued EV/EBITDA
19.75
Undervalued EV/EBITDA
16.31

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PS
3.32
Current PS
3.66
Overvalued PS
3.76
Undervalued PS
2.89

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

    Insider
    Hedge Fund
    Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought

MMSI News & Events

Events Timeline

(ET)
2025-07-16
13:23:41
Merit Medical down 8% after Wells confirms pass-through denial
select
2025-07-16
13:23:02
Merit Medical confirms Wrapsody pass-through denied, says Wells Fargo
select
2025-07-07 (ET)
2025-07-07
17:05:12
Martha Aronson to step down from Conmed board
select
Sign Up For More Events
Sign Up For More Events

News

Preview
2.0
07-17NASDAQ.COM
Merit Medical Systems is Now Oversold (MMSI)

  • Merit Medical Systems Stock Performance: Merit Medical Systems, Inc. (MMSI) shares have reached an oversold status with an RSI of 25.5, indicating potential buying opportunities after recent heavy selling, as the stock traded as low as $83.73.

  • 52-Week Range Analysis: The stock's 52-week low is $82.62 and high is $111.45, with the last trade recorded at $83.95, suggesting it is currently near its lower range.

Preview
4.5
07-09NASDAQ.COM
Stocks Stabilize on Trade Talk Optimism

  • Market Overview: The S&P 500 is up slightly while the Dow is down, as stocks stabilize after recent tariff announcements. President Trump remains open to trade negotiations despite plans to increase tariffs on several countries starting August 1.

  • Earnings and Interest Rates: Upcoming earnings season shows modest growth expectations for S&P 500 companies, with only six sectors projected to see increases. Rising bond yields are limiting stock gains due to inflation concerns linked to higher tariffs.

Preview
4.5
07-09NASDAQ.COM
Stocks Finish Mixed on Strength in Chip Makers and Higher Bond Yields

  • Market Performance: The S&P 500 and Dow Jones closed down slightly, while the Nasdaq 100 saw a small gain, influenced by President Trump's trade rhetoric and rising bond yields, which raised inflation concerns. The upcoming earnings season is expected to show minimal growth in Q2 earnings for S&P 500 companies.

  • Sector Movements: Chip stocks and energy companies performed well, with notable gains from Intel and Devon Energy, while several financial stocks faced downgrades leading to losses. The market remains focused on tariff news and economic indicators, including upcoming FOMC meeting minutes and unemployment claims.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Merit Medical Systems Inc (MMSI) stock price today?

The current price of MMSI is 84.08 USD — it has decreased -0.54 % in the last trading day.

arrow icon

What is Merit Medical Systems Inc (MMSI)'s business?

Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of medical devices used in interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and original equipment manufacturer. Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Its product portfolio of medical devices and accessories is used in lead management procedures for patients who need a pacemaker, or an implantable cardioverter-defibrillator lead removed or replaced. Its products are used in clinical areas, such as radiology, electrophysiology and more. It also manufactures hemostatic devices under the brand names StatSeal and WoundSeal.

arrow icon

What is the price predicton of MMSI Stock?

Wall Street analysts forecast MMSI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MMSI is 107.11 USD with a low forecast of 100.00 USD and a high forecast of 112.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Merit Medical Systems Inc (MMSI)'s revenue for the last quarter?

Merit Medical Systems Inc revenue for the last quarter amounts to 355.35M USD, increased 9.84 % YoY.

arrow icon

What is Merit Medical Systems Inc (MMSI)'s earnings per share (EPS) for the last quarter?

Merit Medical Systems Inc. EPS for the last quarter amounts to 0.49 USD, increased 2.08 % YoY.

arrow icon

What changes have occurred in the market's expectations for Merit Medical Systems Inc (MMSI)'s fundamentals?

The market is revising Upward the revenue expectations for Merit Medical Systems, Inc. (MMSI) for FY2025, with the revenue forecasts being adjusted by 0.45% over the past three months. During the same period, the stock price has changed by -6.16%.
arrow icon

How many employees does Merit Medical Systems Inc (MMSI). have?

Merit Medical Systems Inc (MMSI) has 7400 emplpoyees as of July 18 2025.

arrow icon

What is Merit Medical Systems Inc (MMSI) market cap?

Today MMSI has the market capitalization of 5.00B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free